A GP guide to SGLT2 inhibitors in type 2 diabetes
The benefits and adverse effects of this new class of medications
Diabetes affects approximately 1.2 million Australians, with type 2 diabetes accounting for up to 90% of cases.1-3
The risk of adverse kidney outcomes in patients with type 2 diabetes remains high.